First and foremost, it’s importnat to remember that this isn’t the first announcement of customer adoption that we’ve seen from BioNano Genomics. Just a few weeks ago, the company announced that the University of Iowa and PerkinElmer Genomics had adopted the Saphyr system.
With the new product just starting to make its way through the market, it’s crucial that BNGO take active steps to introduce the product to key players. After all, we know that when the largest, most trusted players in genomics, or any other industry for that matter, adopt a new technology, we tend to see a domino effect of adoption throughout the industry.
It’s clear with the recent news from BNGO that the company is actively taking the steps it needs to in order to successfully commercialize Saphyr and make the system a cornerstone in genomic testing.
All in all, with the strong moves that the company is making at this stage in the game, the stock is quickly becoming one that’s hard to ignore!
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Don’t Miss The Next Big Story!
Join our free mailing list below to receive real-time news alerts!